Gaithersburg, Md. — Animals don't have to suffer for your cosmetics, cleaners, pesticides, or drugs. The PETA International Science Consortium Ltd. is donating $50,000 in equipment to the Institute for In Vitro Sciences (IIVS), a nonprofit laboratory in Gaithersburg that conducts and develops animal-free test methods. IIVS will use the VITROCELL® Cloud inhalation exposure system — instead of animals — to assess the effects of substances on the human respiratory tract. Manufactured by German-based VITROCELL Systems, the Cloud system mimics realistic human exposure to chemicals that may be inhaled. It yields more human-relevant results than the current method of forcing rats in narrow tubes to inhale toxic substances for hours before finally being killed. "The PETA International Science Consortium is committed to helping researchers conduct animal-free inhalation testing, and one of the best ways to do this is by donating essential equipment," says Dr. Amy Clippinger, president of the Science Consortium. "The Cloud system is an important addition to IIVS' respiratory toxicology laboratory, and we're confident that this donation will lead to better protection of human health and spare animal lives." "We are very appreciative of the Science Consortium's continued support of our mission," says Erin Hill, president of IIVS. "This donation allows us to expand from an initial focus on tobacco to address the respiratory toxicology needs of the personal care industry." Today's announcement follows the Science Consortium's 2017 award of $400,000 of VITROCELL® equipment to four laboratories in the U.S., the U.K., and Belgium. Along with awarding testing equipment to replace the use of animals in inhalation testing, the Science Consortium funds the development of animal-free methods, hosts webinars and workshops, and much more.
###The PETA International Science Consortium Ltd. works to accelerate the development, validation, and global implementation of animal-free testing. It was established in 2012 to coordinate the scientific and regulatory expertise of its members — PETA U.S., PETA U.K., PETA Germany, PETA India, PETA Netherlands, PETA France, PETA Asia, and PETA Australia. The Science Consortium and its members have donated millions of dollars toward helping to reduce and replace animal use. The Institute for In Vitro Sciences, Inc., is a nonprofit research and testing laboratory dedicated to the advancement of in vitro (non-animal) methods worldwide. Founded in 1997, the Institute is unique in its position as a high-quality testing laboratory while also offering technical and educational resources to advance the field. For more information, please visit PISCLtd.org.uk or IIVS.org.
The US EPA has committed to dramatically reducing animal testing with a commitment for total elimination by the year 2035. IIVS is proud to have played a part in the move to reduce animal testing, starting with the successful development, and acceptance, of the non-animal eye-irritation defined approach, which was developed by an industry and regulatory consortium led by IIVS' CEO Rodger D. Curren, Ph.D. IIVS looks forward to continuing its collaboration with stakeholders to help the agency achieve its goals. Read the EPA Press Release.
IIVS is excited about meeting attendees of the 55th EUROTOX conference! Please join us at booth #34 to meet our representatives who are looking forward to discussing trends and New Methodologies in Alternative Approaches (NAMs) to toxicological research, as well providing updates on services offered by our organization! Also, don’t miss our posters: The kinetic Direct Peptide Reactivity Assay (kDPRA): An in chemico method to characterize the skin sensitization potency of chemicals (Poster Viewing 1) Increased Throughput and Cryopreservation of Precision-Cut Lung Slices Extend the Utility of Human-Relevant, 3-Dimensional Pulmonary Test Systems (Poster Viewing 2) Promoting the uptake of alternatives to animal testing through the development of eLearning tools (Poster Viewing 2) Check out the program for EUROTOX 2019.
The Italian Health Ministry recently announced the creation of a working group for the promotion of alternative methods. Experts on alternative methods, along with stakeholders, will meet monthly and update the health minister every six months. The group has been tasked with a number of responsibilities, including ensuring the proper implementation of the 2013 EU ban on animal testing for cosmetics and the correct use — and adequate funding — of alternative methods. More Information:
Gaithersburg, MD – May 8, 2019 – The Institute for In Vitro Sciences, Inc. (IIVS) has received a grant from the European Partnership for Alternative Approaches to Animal Testing (EPAA) to support its annual training of Chinese scientists in non-animal testing methods. As part of the agreement, two scientists from BASF SE, a member of EPAA, will join IIVS to provide hands-on training in China for four non-animal approaches for skin sensitization. This training follows the recent announcement by China’s National Medical Products Association (NMPA) of acceptance of one non-animal method for skin sensitization, DPRA, which will be included in the training. “We are proud to have the support of EPAA for our training program(s) which are designed to build proficiency and capacity in non-animal test methods in China,” states Erin Hill, President of IIVS. “We approached BASF scientists to assist us, given their technical proficiency in the tests and experience in providing training. Their inclusion allows us to provide a comprehensive training of internationally validated test methods, as well as introducing a newly developed method, the Kinetic DPRA.” IIVS’ annual training is part of a Memorandum of Understanding between IIVS and China’s National Institute for Food and Drug Control (NIFDC), a technical subordinate agency of the NMPA. IIVS and the NIFDC work together to assist Chinese scientists in becoming proficient in non-animal test methods to support China’s movement toward accepting alternative tests for the regulation of cosmetics. Recently IIVS was appointed to the NIFDC’s Alternatives Working Group. IIVS and EPAA have collaborated previously to produce full length training videos for non-animal test methods which have been translated into Chinese, Portuguese and Spanish. These videos are available free of charge at the EPAA website, YouTube, and also distributed at IIVS trainings. Similarly, BASF and IIVS have collaborated over the years to promote the development and standardization of in vitro test methods. Most recently the two organizations worked to officially import the LuSens cells into China where they will be maintained at the NIFDC and distributed to appropriate laboratories. The LuSens assay for skin sensitization will also be taught in the 2019 training course. About the Institute for In Vitro Sciences (IIVS) IIVS is a non-profit organization wholly dedicated to the promotion of non-animal test methods. Founded in 1997, IIVS is recognized as a leading provider of in vitro testing in support of toxicological safety evaluations. Rigorous scientific programs coupled with educational and outreach initiatives have established IIVS as a global leader in the advancement of alternatives to animal testing. For more information, visit us at www.iivs.org. Media Contact: Erin Hill President Phone: 301-947-1281 Ehill@iivs.org
The past seven days saw both Colombia and Canada make strides towards banning animal testing for cosmetics. In Colombia, the House of Representatives unanimously approved a bill to prohibit the use of animals in testing for both cosmetics and personal care products. The bill will now move to the Senate for a vote. If approved there, the law would come in to affect within a year of the vote. A promising first step was taken in Canada where a bill advocating for the ban of animal testing in cosmetics was brought forward for its first reading in the House of Commons. At this stage, the bill still has a number of steps before it will be voted upon by the House of Commons and passed to the Senate for their vote.
The two day training, NURA: Evaluating Toxicology Information using Modern Science, will be held at IIVS on May 21-22, 2019. Training will be presented by regulators, industry personnel, and toxicology experts and will focus on how to incorporate modern methods into your testing strategies and safety assessments. Register now to secure your spot.
IIVS is pleased to congratulate Jan van der Valk, Ph.D., director of the 3Rs-Centre Utrecht Life Sciences, who has been awarded the Björn Ekwall Memorial Award for 2019 for his work to encourage the replacement of fetal bovine serum (FCS) in cell culture medium. Additionally, he has been recognized for establishing the fetal bovine serum free database, a forum to allow discussion between researchers on the applicability of alternatives to FCS.